Scoop has an Ethical Paywall
The Insides Company
The Insides Company is a leading provider of chyme reinfusion solutions for intestinal failure
The Insides Company - Latest News [Page 1]
The Insides Company Announces First-Patient-In (FPI) Milestone Completed For The REINFUSE Study
Wednesday, 23 November 2022, 5:03 am | The Insides Company
The Insides™ Company , a leading provider of automated chyme reinfusion solutions, today announced the first patient has been enrolled in the REINFUSE clinical study. REINFUSE is a Pivotal study to evaluate the safety and efficacy of The Insides™ ... More >>
The Insides™ Company Launches The World’s First Chyme Reinfusion Medical Registry
Thursday, 7 July 2022, 5:35 am | The Insides Company
The Insides™ Company is proud to announce the launch of a first in world chyme reinfusion medical registry. The use of medical registries to understand the efficacy and safety of treatments has been a key part of post market assessment for many years. ... More >>
The Insides™ Company Announces The Insides™ System For Chyme Reinfusion Is Now Available On The NHS Supply Chain
Thursday, 2 June 2022, 12:18 pm | The Insides Company
The Insides™ Company is pleased to announce that The Insides™ System and The Insides™ Refill have been added to the NHS Supply Chain in the UK. The Insides Company’s award-winning flagship product, The Insides™™ System, is a patient ... More >>
The Insides Company CEO Garth Sutherland, Announced As Top 50 Healthcare Technology CEOs Of 2022
Wednesday, 25 May 2022, 2:35 pm | The Insides Company
Garth Sutherland, CEO of The Insides Company, was announced as one of the Top 50 Healthcare Technology CEOs of 2022, by The Health Technology Report . The Insides Company is a leading provider of gastrointestinal medical devices for patients with ... More >>
The Insides Company And GD Medical Announce Distribution Agreement For The Netherlands And Belgium
Monday, 4 April 2022, 9:56 am | The Insides Company
Left to Right: Ingrid Evers (Marketing Manager at GD Medical), Duncan Cunninghame (Business Development Manager UK & EU at The Insides Company), Roel Claassen (Managing Director of GD Medical) GD Medical Pharma BV has been appointed as the ... More >>
The Insides Co Announces NICE Medtech Innovation Briefing (MIB) For The Insides™ System For Severe Intestinal Failure
Monday, 21 March 2022, 5:34 pm | The Insides Company
The Insides Company is pleased to announce that the National Institute for Health and Care Excellence (NICE) has released Medtech Innovation Briefing 286 (MIB286), titled “The Insides System for managing intestinal failure”. MIB286 is available ... More >>
The Insides Company & MM Surgical Announce Slovenian Distribution Agreement
Monday, 21 March 2022, 5:32 pm | The Insides Company
The Insides Company is pleased to announce the appointment of MM Surgical as the exclusive distributor of The Insides Company's chyme reinfusion solutions in Slovenia. The Insides Company’s award-winning flagship product, The Insides™ System, is ... More >>
The Insides Company And MM Surgical Announce Distribution Agreement For Slovenia
Monday, 21 March 2022, 12:41 pm | The Insides Company
The Insides Company is pleased to announce the appointment of MM Surgical as the exclusive distributor of The Insides Company's chyme reinfusion solutions in Slovenia. The Insides Company’s award-winning flagship product, The Insides™ System, is ... More >>
The Insides™ Company Appoints UK Non-Executive Director And Advisors
Monday, 14 February 2022, 1:19 pm | The Insides Company
The Insides™ Company Limited, a leading provider of automated chyme reinfusion solutions, is pleased to announce the appointment of Mr Douglas Le Fort as Non-Executive Director, and Mr Anthony Fife as Commercial Advisor, to the company. Both Mr Le Fort, ... More >>
The Insides Co. Partners With GBUK Group To Provide Chyme Reinfusion Devices To The United Kingdom & Ireland
Thursday, 10 February 2022, 4:18 pm | The Insides Company
The Insides™ Company is proud to announce it has partnered with GBUK Group to provide The Insides™ range of chyme reinfusion medical devices into the United Kingdom and Ireland. This includes the award winning The Insides System that is used ... More >>
Feasibility Study on Postoperative Outcomes of Ileostomy Patients using The Insides™ System Published in Diseases of Colon & Rectum
Wednesday, 13 October 2021, 1:20 pm | The Insides Company
In October 2021, a feasibility study assessing the postoperative outcomes of ileostomy patients performing automated chyme reinfusion using The Insides™ System, titled " Stoma-Output Reinfusion Device for Ileostomy Patients ”, was published in ... More >>
The Insides Company And OptiMed Technologies Announce Australia Distribution Agreement
Wednesday, 30 June 2021, 9:21 am | The Insides Company
OptiMed Technologies Pty has been appointed as the exclusive distributor for The Insides Company’s therapeutic chyme reinfusion solutions for Australia. Garth Sutherland, CEO of The Insides Company said "The Insides Company is very excited for our ... More >>
